Ning Lv

1.9k total citations
71 papers, 1.3k citations indexed

About

Ning Lv is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Ning Lv has authored 71 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 17 papers in Molecular Biology. Recurrent topics in Ning Lv's work include Lymphoma Diagnosis and Treatment (7 papers), Lung Cancer Treatments and Mutations (7 papers) and HER2/EGFR in Cancer Research (6 papers). Ning Lv is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Lung Cancer Treatments and Mutations (7 papers) and HER2/EGFR in Cancer Research (6 papers). Ning Lv collaborates with scholars based in China, United States and Switzerland. Ning Lv's co-authors include Yanan Kong, Xiaohui Fan, Rui Xue, Ni Ai, Xin Shao, Jie Liao, Donghang Xu, Peihong Wu, Ni He and Xiaoming Xie and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Agricultural and Food Chemistry.

In The Last Decade

Ning Lv

69 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ning Lv China 22 482 373 304 290 163 71 1.3k
Ming Jin China 20 643 1.3× 452 1.2× 351 1.2× 225 0.8× 89 0.5× 79 1.5k
Christos Vaklavas United States 19 525 1.1× 574 1.5× 304 1.0× 278 1.0× 114 0.7× 55 1.4k
Małgorzata Oczko‐Wojciechowska Poland 21 690 1.4× 265 0.7× 266 0.9× 210 0.7× 98 0.6× 61 1.4k
Zhikun Liu China 23 653 1.4× 411 1.1× 394 1.3× 259 0.9× 96 0.6× 115 1.5k
Xin An China 24 823 1.7× 689 1.8× 452 1.5× 398 1.4× 135 0.8× 102 2.1k
Zhonghua Wang China 20 415 0.9× 683 1.8× 265 0.9× 409 1.4× 80 0.5× 57 1.3k
Magdolna Dank Hungary 19 419 0.9× 730 2.0× 394 1.3× 499 1.7× 166 1.0× 120 1.5k
Tamami Morisaki Japan 20 472 1.0× 619 1.7× 385 1.3× 230 0.8× 64 0.4× 98 1.2k
Michael Xiang United States 16 475 1.0× 351 0.9× 203 0.7× 295 1.0× 51 0.3× 68 1.1k
Yuee Teng China 25 941 2.0× 578 1.5× 491 1.6× 273 0.9× 106 0.7× 86 1.6k

Countries citing papers authored by Ning Lv

Since Specialization
Citations

This map shows the geographic impact of Ning Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Lv more than expected).

Fields of papers citing papers by Ning Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ning Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Lv. The network helps show where Ning Lv may publish in the future.

Co-authorship network of co-authors of Ning Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Ning Lv. A scholar is included among the top collaborators of Ning Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ning Lv. Ning Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fu, Yuxuan, Ning Lv, Jia Wang, et al.. (2025). miR‐135b‐5p/PDE3B Axis Regulates Gemcitabine Resistance in Pancreatic Cancer Through Epithelial‐Mesenchymal Transition. Molecular Carcinogenesis. 64(6). 1119–1130. 1 indexed citations
2.
Sun, Xiaolin, Chaorui Guo, Chunyan Huang, et al.. (2024). GSTP alleviates acute lung injury by S-glutathionylation of KEAP1 and subsequent activation of NRF2 pathway. Redox Biology. 71. 103116–103116. 16 indexed citations
3.
Li, Gangqiang, et al.. (2023). Effects of Gestational Diabetes Management on Pregnancy Outcome. OALib. 10(2). 1–11. 1 indexed citations
4.
Lv, Ning, et al.. (2023). Overexpression of Glutathione S-Transferases in Human Diseases: Drug Targets and Therapeutic Implications. Antioxidants. 12(11). 1970–1970. 25 indexed citations
5.
Nie, Chun‐Hui, et al.. (2021). Protopine triggers apoptosis via the intrinsic pathway and regulation of ROS/PI3K/Akt signalling pathway in liver carcinoma. Cancer Cell International. 21(1). 396–396. 26 indexed citations
6.
Munster, Sanne N. van, Liyan Xue, Shun He, et al.. (2019). Prospective study of endoscopic focal cryoballoon ablation for esophageal squamous cell neoplasia in China. Gastrointestinal Endoscopy. 90(2). 204–212. 7 indexed citations
7.
8.
He, Ni, Yanan Kong, Ning Lv, et al.. (2015). The utility of breast cone-beam computed tomography, ultrasound, and digital mammography for detecting malignant breast tumors: A prospective study with 212 patients. European Journal of Radiology. 85(2). 392–403. 58 indexed citations
9.
Liu, Dongfeng, et al.. (2014). Determination of ethylene glycol, 1,2-propanediol and 1,3-propanediol in wet flour products by gas chromatography.. Shipin anquan zhiliang jiance xuebao. 5(12). 3870–3874. 1 indexed citations
10.
Sun, Wei, et al.. (2014). Significance of nonmucinous lepidic component with mild nuclear atypia in the discrimination of multiple primary lung cancers from intrapulmonary metastases.. PubMed Central. 7(11). 7583–96. 9 indexed citations
11.
Zou, Xiao, Dongmei Lin, Ann Chao, et al.. (2014). Histological subtypes of lung cancer in Chinese women from 2000 to 2012. Thoracic Cancer. 5(5). 447–454. 14 indexed citations
12.
Dou, Lizhou, Yueming Zhang, Shun He, et al.. (2013). A control study of endoscopic mucosal resection and endoscopic submucosal dissection in treating rectal carcinoid tumors. Zhonghua xiaohua neijing zazhi. 30(4). 209–213. 2 indexed citations
13.
14.
Lv, Ning, Suxia Lin, Zeming Xie, et al.. (2012). Absence of evidence for epidermal growth factor receptor and human homolog of the Kirsten rat sarcoma-2 virus oncogene mutations in breast cancer. Cancer Epidemiology. 36(4). 341–346. 4 indexed citations
15.
Wu, Minqing, Weidong Wei, Xiangsheng Xiao, et al.. (2012). Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer. Medical Oncology. 29(5). 3240–3249. 72 indexed citations
16.
Lv, Ning, Yun Cao, Xi Wang, et al.. (2012). A case report of primary small cell carcinoma of the breast and review of the literature. Chinese Journal of Cancer. 31(7). 354–8. 9 indexed citations
17.
Xie, Xinhua, Jiaoli Guo, Yanan Kong, et al.. (2011). Targeted expression of Escherichia coli purine nucleoside phosphorylase and Fludara® for prostate cancer therapy. The Journal of Gene Medicine. 13(12). 680–691. 17 indexed citations
18.
Lv, Ning, Xiaoming Xie, Suxia Lin, et al.. (2011). Epidermal growth factor receptor in breast carcinoma: association between gene copy number and mutations. Diagnostic Pathology. 6(1). 118–118. 30 indexed citations
19.
Zhang, Yueming, Shun He, Changqing Hao, et al.. (2007). Evaluation of narrow-banding imaging endoscopy in the diagnosis of early squamous esophageal cancer and precancerous lesions. Zhonghua xiaohua neijing zazhi. 24(6). 410–414. 2 indexed citations
20.
Li, Ye‐Xiong, Bo Yao, Jing Jin, et al.. (2005). Radiotherapy as primary treatment for Stage IE and IIE nasal NK/T cell lymphoma. 27–27. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ming Jin Breakdown of academic impact, for papers by Christos Vaklavas Breakdown of academic impact, for papers by Małgorzata Oczko‐Wojciechowska Breakdown of academic impact, for papers by Zhikun Liu Breakdown of academic impact, for papers by Xin An Breakdown of academic impact, for papers by Zhonghua Wang Breakdown of academic impact, for papers by Magdolna Dank Breakdown of academic impact, for papers by Tamami Morisaki Breakdown of academic impact, for papers by Michael Xiang Breakdown of academic impact, for papers by Yuee Teng
Rankless by CCL
2026